相关实验视频
Updated: Jul 26, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
未来深度大脑刺激手术的预测者 de novo 帕金森病
Stefan Lang1, Artur Vetkas1, Christopher Conner1
1Division of Neurosurgery, Department of Surgery University of Toronto Toronto Ontario Canada.
Movement disorders clinical practice
|June 19, 2023
概括
某些早期帕金森病 (PD) 症状和生物标志物预测需要进行深度脑刺激 (DBS) 手术. 识别这些特征有助于对PD患者的早期手术候选人评估.
科学领域:
- 神经科学和神经病学 神经科学和神经病学
- 生物标志物和诊断方法
- 手术干预 手术干预
背景情况:
- 深度大脑刺激 (DBS) 是帕金森病 (PD) 患者的一个子集的手术选择.
- 在新的PD患者中,对未来的DBS手术的诊断预测因素仍然不清楚.
研究的目的:
- 确定基线临床,成像和生物标本特征,预测新诊断的PD患者最终的DBS手术.
- 分析DBS手术的PD患者的疾病进展模式,与没有接受DBS手术的患者相比.
主要方法:
- 利用了来自帕金森病进展标志物倡议 (PPMI) 数据库的数据,其中包括416名PD患者.
- 在50个基线特征中使用交叉验证的拉索回归来减少特征.
- 应用多变量逻辑回归和接收器操作特征 (ROC) 曲线分析,以评估预测因素和模型性能.
主要成果:
- 症状发病时的年龄,霍恩和雅尔 (H&Y) 阶段,震得分和CSF Tau:粉样蛋白-β 1-42比率是 DBS 手术的显著预测因素 (AUC=0.83).
- 没有接受DBS (DBS-) 的患者在4年内表现出更快的记忆衰退.
- 接受DBS (DBS+) 的患者在手术前的H&Y阶段和运动得分下降速度更快.
结论:
- 确定基线特征可以促进早期识别PD中潜在的DBS外科候选人.
- 独特的疾病进展模式 (认知与运动) 与PD患者的手术资格和结果相关.
更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.8K
相关概念视频
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:15Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611